sinkalan2015 when I see some ppl here trying to compare GPacket with Scomnet, I finally know why so many people lose money even though the market is not that bad. 26/06/2020 1:59 PM
Aiyo... Decent counter also does NOT warrant crazy PE ma... that's why there is a term called BUBBLE .....So when Bubble POP then whoever gets out LAST will kena burn lo.....
Most investors never read the annual report so they don't know the details. Page 19 of the annual report under Management Discussion and Analysis : "Outlook for 2020." " Overall, we expect SMP (Supercomal Medical Products)'s revenue to increase by 30% to 40% in FY2020." Only its automotive cable segment revenue will drop by about 20% in FY2020. " The Group is sanguine to record another year of remarkable financial performance,even as the global business environment is hit by the Covid-19 pandemic." By the way, SMP contributes about 90% of the total profits of the Group.
Extract from relevant section of the annual report :MANAGEMENT DISCUSSION AND ANALYSIS (Cont’d) Outlook for FY2020 We are cognizant of the fact that the global business environment has been significantly shaken by the COVID-19 pandemic and the containment measures introduced by governments globally to deal with the virus outbreak. Terming the current crisis as the “Great Lockdown”, the International Monetary Fund forecasts the world economy to contract by 3% in 2020, which is the worst performance since the 1929 Great Depression. In the case of Malaysia, the Washington-based organisation projected Malaysia’s economy to contract by 1.7%, as compared to a positive growth of 4.3% in 2019. Inevitably, global economic slowdown and supply chain disruptions will have a negative impact on domestic business sentiment and consumer purchasing behaviour. Additionally, the long Movement Control Order (MCO) imposed by the Malaysian government from March 18, 2020 to May 4, 2020 and Conditional MCO thereafter until June 9, 2020 will also further drag down local economic activities. Amid such a challenging environment, the Group will not be spared from seeing some adverse impact as a result of the current economic crisis and the COVID-19 outbreak. The operations of STB and SAC will be affected on three fronts namely, curtailed production levels during the MCO period, shortage of raw material supply and the decline in the overall demand for cables and wires, especially from automotive sector customers. Taking these factors into consideration, we estimate that the revenue of STB and SAC will drop by about 20% in FY2020. Fortunately, the Group could offset the lost revenue, and in fact record stronger sales, on the back of its medical device cable manufacturing business through SMP. Being a beneficiary of the COVID-19 pandemic, SMP has seen a surge in demand for cables used in the manufacturing of medical devices that are critical to treat affected patients. With a stronger business volume from existing and new clients, we are confident that SMP will help the Group sail out of troubled waters. In addition, with several new products in the pipeline for 2020, this will provide further boost to the Group’s financial performance. Overall, we expect SMP’s revenue to increase by 30% to 40% in FY2020. Moving forward, the Group remains focused on achieving its long-term goal of being a global OEM player in the automotive cables and medical devices industry. Supported by the Board of Directors’ visionary direction and the Management’s continued efforts to drive business without compromising on corporate governance, the Group is sanguine to record another year of remarkable financial performance, even as the global business environment is hit by the COVID-19 pandemic.
Their products are directly used in the treatment of COVID-19 patients: It should be noted that several key products of SMP are utilised in critical medical devices that are needed in the treatment of COVID-19 patients. Among the critical medical devices are disposable bronchoscopes, which are used in the first line of lung treatment for patients with suspected or confirmed COVID-19 infections, and the critical care monitoring cable that is presently being used for COVID-19 patients in the Intensive Care Unit. The fact that SMP is also a key customer of STB’s wires and cable manufacturing business is also a major plus point for the Group. This is because an increase in product orders for SMP on the back of higher demand for medical devices, will also mean increased orders from SMP to STB’s wires and cable manufacturing business.
Reality check. COVID-19 related number of cases are insignificant compared to other health areas in any hospitals. Just because there is a new disease, you will not see significant impact on revenue growth.
Ppl just justify and justify to satisfy themselves without even looking at the overvalued price of scomnet. Current scomnet price is clearly overvalued compare to its current financial
@t Nike_2002 where is the hardcore promoters like @gemsh...? So quiet now... Hai dude long time no see u in this scomnet forum... u got huat ma... Now u are yspsah hardcore promoter... wow Monday can buy in ah..
@t Nike 2002 ...Scomnet giv me huat leh from the day I promote till now... so now my bullet vry strong oh... any recommendations for me to buy ... haha
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
CoolJay
831 posts
Posted by CoolJay > 2020-06-26 14:12 | Report Abuse
Calm the fck down la.. This company fundamentals is good. Nuff said. Stop speculating.